Jean Tassel

Title: Innovations of Jean Tassel in Kinase Modulation

Introduction

Jean Tassel is a notable inventor based in Augsburg, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate various kinases. His work focuses on addressing complex diseases, including autoimmune and neurodegenerative disorders.

Latest Patents

Jean Tassel holds a patent for "1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as LRRK2, NUAK1 and/or TYK2 kinase modulators for the treatment of e.g. autoimmune disease." This invention relates to compounds capable of modulating kinases, especially LRRK2, NUAK1, and TYK2. The compounds are designed to treat a wide range of diseases, including autoimmune diseases, inflammatory diseases, and various cancers. The patent details the synthesis and characterization of these compounds, providing pharmacological data and examples of preferred compounds.

Career Highlights

Jean Tassel is currently associated with Origenis GmbH, where he continues to innovate in the field of drug development. His work has led to advancements in understanding how kinase modulation can impact the treatment of serious health conditions. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Jean has collaborated with notable colleagues, including Roland Koestler and Michael Thormann. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Jean Tassel's contributions to kinase modulation represent a significant advancement in the treatment of various diseases. His innovative work continues to pave the way for new therapeutic options in the medical field.